Nymox Pharmaceutical Corporation
… working to introduce a new, safe, efficacious and long-lasting therapy to the millions of men suffering from an enlarged prostate gland (BPH).
Fexapotide for BPH
For the treatment of Benign Prostate Hyperplasia (BPH)
Recent scientific publications featuring Fexapotide Triflutate
March 21, 2023
Nymox Announces Appointment of Christopher R. Riley as Chief Financial Officer